Latest Activity

Krishna kumar yadav shared a profile on Facebook
9 hours ago
Krishna kumar yadav updated their profile
9 hours ago
B. Rymbai updated their profile
Monday
Sathishkumar and Vijay Kumar Pagidikathula are now friends
Monday
Nidhi kushwaha updated their profile
Sunday
Bidyut Bikash Kalita posted a blog post
Sunday
Evana Mukherjee updated their profile
Jun 24
Amit joined Dr. Badan Barman's group
Jun 23
Amit joined Dr. Badan Barman's group
Jun 23
S. Jaffer Basha shared a profile on Facebook
Jun 21
Babita Kumari updated their profile
Jun 19
Vijay Anand Thorat updated their profile
Jun 18
Rajesh Chandra Das updated their profile
Jun 17
DR*(MRS)BALVINDER KUMARI is now friends with Rohit Jangra and Amit
Jun 16
N.KAPILESH updated their profile
Jun 16
Dr. U. PRAMANATHAN posted a blog post
Jun 15
ARUN PRASAD posted a blog post
Jun 15
Poonam posted a blog post
Jun 15
Kinnera Mukesh posted a discussion
Jun 15
Nagappa Veerappa Bakkannanavar posted an event
Jun 15
HARI DATT PANDEY
  • Male
Share on Facebook

HARI DATT PANDEY's Friends

  • Siddhartha Shankar Ray
  • Dr. Badan Barman

HARI DATT PANDEY's Forum

Current Scenario of IPR with Reference to Copyright on Information Services in India: A Study
1 Reply

Respected Sir /Madam,I am a student from Indira Gandhi National Open University doing my MLIS (Master’s Degree in Library and Information Science), as per the project requirement we are conducting a…Continue

Started this Forum. Last reply by Siddhartha Shankar Ray Feb 20, 2013.

 

HARI DATT PANDEY's Page

Latest Activity

HARI DATT PANDEY and Dr. Badan Barman are now friends
Dec 14, 2023
HARI DATT PANDEY posted a status
"What are you up to?"
Dec 14, 2023

Profile Information

Type of Working Institute
IGNOU NEW DELHI IN JUNE 2011
Name of the Indian State of Permanent Residential Address
Punjab

Comment Wall (3 comments)

You need to be a member of LIS Links to add comments!

Join LIS Links

At 17:33 on April 20, 2014, Mrs.Balvinder Kumari said…
At 0:07 on April 2, 2013, Siddhartha Shankar Ray said…

Dear Sri Pande:

As I understand that with the recent patent battle regarding certain anti-carcinogenic drugs, the Swiss Multinational Novartis has opted to shrink its R&D investment in India. Do you feel that it will enhance your R&D activities especially in the fields of Vaccine Development & monoclonal antibodies? I am interested to know. However, in case it, in any way,create any possibility to affects your policy secrecy, please do not write anything.

Best Wishes,

Siddhartha S. Ray, Calcutta

At 21:31 on November 5, 2012, HARI DATT PANDEY said…

Dear Sir / Madam,
I am not for a students of LPU. i am presently doing MLISc. from IGNOU new Delhi.
Kindly currect the my profile.

 
 
 

© 2026   Created by Dr. Badan Barman.   Powered by

Badges  |  Report an Issue  |  Terms of Service

LIS Links whatsApp